Back to Report Store Home

Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player

  • Published: Jul-2011
  • Report Code: GBIHC102MR
  • Report Format: pdf

Description

GBI Research has released its latest report, “Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player” that provides key data, information and analysis of the major trends and issues affecting the Clinical Trial market in Russia. The report provides a comprehensive insight of reasons for outsourcing clinical trials to Russia. The report also provides a detailed analysis of Russian clinical trial market structure. Analysis of major companies and countries which sponsor clinical trials in Russia is provided. Patient population analysis is done to highlight the types of diseased population available for conducting clinical trials in Russia. Opinion of industry experts has been incorporated in various parts of the report to emphasize the importance of various factors that affect the clinical trial market scenario in Russia.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research’s team of industry experts.

Scope

  • The scope of the report includes:

  • The need for outsourcing clinical trials to Russia

  • Major companies and countries which sponsor clinical trials in Russia

  • Trends in clinical trial registration in Russia

  • Analysis of the key drivers and restraints that are impacting the growth of Clinical trial market in Russia

  • Qualitative analysis of the key Infrastructural facilities present for conducting clinical trials in Russia

  • Analysis of new federal law “On circulation of medicine” and its impact on clinical trials market in Russia.

  • Study of 11 key CROs operating in Russia.

Reasons To Buy

  • The report will enhance your decision making capability. It will allow you to:

  • Compare the key capabilities of major clinical trial service providers with your requirements and optimize your R&D costs

  • Develop market entry and market expansion strategies by identifying the key drivers and challenges in Russian market

  • Develop effective strategies to maximize the advantages in Russia through the understanding of the regulatory environment

  • Understand the regulatory structure in Russia and key documents required to register clinical trial in Russia

  • Gain knowledge about the major indications for which clinical trials can be conducted in Russia

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards